03/03/2026
More than 100,000 people in 🇨🇭 depend on insulin every day.
Yet global market shifts and supply vulnerabilities are reshaping the security of this life-saving medicine.
At the end of 2025, the NCD Policy Lab reported that insulin shortages and stock-outs are occurring across all regions and income levels.
So what’s next?
This new policy brief focuses on Switzerland, to show that in 2026, access to cannot be taken for granted, even in high-income settings.This isn’t meant to be a perfect document, and that’s exactly the point.
It’s shared to
➡️ Start a conversation
➡️ Invite your perspectives and
➡️ Offer a resource the diabetes community can adapt, challenge, and build on
Swap Switzerland for your country.
Reuse the arguments.
Update the data.
Make it yours.
📄 Read the policy brief:
https://ncdpolicylab.org/resources/policy-briefs/access-to-insulin-no-longer-just-an-issue-for-low-and-middle-income-countries-should-switzerland-be-worried